Buenavista, Maura E.
HRN: 20-72-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2024
04/11/2024
IV
4.5gm
QID
Lung Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes